Factory supply high quality Isoxepac 99% 55453-87-7

CAS No.: 55453-87-7
Appearance: white powder
Purity: 98.5% min
Synonyms:6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid;(11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid;11-Oxo-6,11-dihydrobenz(b,e)oxepin-2-acetic acid ;2-(11-oxo-6H-benzo[c][2]benzoxepin-2-yl)acetic acid;
Molecular Formula: C16H12O4
Molecular Weight: 268.2641
Loss on drying: 0.5% max
Residue on ignition: 0.2% max
Melting point: 130-132°C
Density: 1.349 g/cm3
Boiling Point: 528.2℃ at 760 mmHg
Flash Point: 203.8℃
Uses: Non-steroidal anti-inflammatory with analgesic and antipyretic activity.

Main Function
For the treatment of duodenal ulcers, gastric ulcers, reflux esophagitis, Zollinger-Ellison syndrome and other high gastric acid secretion diseases.

Applications
Pharmaceutical intermediates and organic synthesis
Indications/Functional Indications For the treatment of duodenal ulcers, gastric ulcers, reflux esophagitis, Zollinger-Ellison syndrome and other high gastric acid secretion diseases.

Factory supply high quality Isoxepac 99% 55453-87-7
Isoxepac is a non-steroidal aryl acetic acid derivative, usually used as pharmaceutical intermediate. It is a non-steroidal anti-inflammatory with analgesic and antipyretic activity.
Isoxepac (also known) as HP-549 is a non-steroidal anti-inflammatory drug with analgesic activity. Isoxepac was studied in the clinical trial for the treatment of postoperative pain after knee surgery for meniscectomy. It was shown, that 200 mg of isoxepac would appear to be the minimal effective dose. In case of rheumatoid arthritis, isoxepac showed significantly fewer adverse effects.
Isoxepac is used for the treatment of duodenal ulcers, gastric ulcers, reflux esophagitis, Zollinger-Ellison syndrome and other high gastric acid secretion diseases.